Author Review — Track Authors' Data

Visual summary (publications & citations)

Evidence base — what the records show

• Publication & citation metrics: OpenAlex lists 13 works, 523 total citations, and h-index = 10 for Jerren Ho; the counts_by_year show a publication surge in 2023 (6 works) consistent with intense SARS-CoV-2 variant-focused output (OpenAlex aggregate).
• Top collaborative venues: Ho is middle-author on multi-group papers in high-impact journals (Nature, Lancet Infectious Diseases, NEJM letters), indicating contributions within a well-resourced collaborative network (Aaron Diamond/Columbia groups).
• Scientific focus: Author concepts center on antigenicity, neutralisation, spike protein mutations, and variant surveillance — coherently consistent across his highest-cited works.

Key primary sources (examples):

• BA.2.86 Nature paper
• EG.5.1 & XBC.1.6 letter
• OpenAlex author record

Critical appraisal — strengths, limitations, blindspots

Strengths

• Consistent involvement in rapid-response neutralisation/antigenicity studies published in high-visibility venues, indicating practical experimental competence in serological assays and variant surveillance (see Nature, Lancet examples above).
• Contribution to multiple rapid-communication letters and preprints — demonstrates ability to produce time-sensitive, policy-relevant data (e.g., neutralisation of new subvariants; NEJM/letter formats).
• Position within established collaborative groups (Aaron Diamond/Columbia) amplifies access to assays, sera panels, and structural expertise; this network effect plausibly increases impact and reproducibility potential.

Limitations & possible blindspots

• Middle-author status on most high-impact pieces makes attribution of independent intellectual leadership unclear; limited record of first- or last-author original mechanistic papers (OpenAlex shows primarily middle-author contributions).
• Bibliometric metrics are modest (13 works, h-index 10) consistent with an early-to-mid career researcher; citation counts concentrated in collaborative, high-profile consortium papers rather than many independent reports.
• Potential biases: reliance on rapid-response letters/preprints risks limited methodological detail and reproducibility; these formats can prioritize speed over exhaustive controls (common in variant surveillance literature) — users should check full methods in each paper before inferring robustness.

What would change this assessment

• More first/last-author peer-reviewed full research articles showing independent experimental programs (e.g., novel assays, longitudinal cohort analyses, or mechanistic structure–function studies) would raise scores markedly.
• Availability of an ORCID, institutional profile, and open data/code linked to papers would improve transparency and reproducibility signals.

Practical recommendations to strengthen scientific standing

1. Aim for more lead-author, full-length research articles that detail methods, raw data, and controls — these increase signals of independent research capability and reproducibility.
2. Deposit raw neutralisation datasets and code (e.g., neutralisation titration curves, sera/sample metadata) in public repositories and link via DOIs to papers — improves transparency and reusability.
3. Create or claim an ORCID and institutional profile, and ensure consistent author name disambiguation across databases (reduces attribution noise in bibliometrics).

Cited primary sources used in this review

• BA.2.86 Nature paper
• EG.5.1 & XBC.1.6 letter
• OpenAlex author record

Want a deeper, evolving analysis (author disambiguation, network co-authorship graph, citation dynamics, or automated extraction of raw neutralisation curves)?